Intellipharmaceutics International Price History

IPCIFDelisted Stock  USD 0.04  0.00  0.00%   
If you're considering investing in Intellipharmaceutics OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Intellipharmaceutics stands at 0.04, as last reported on the 12th of December 2024, with the highest price reaching 0.04 and the lowest price hitting 0.04 during the day. We have found twenty-four technical indicators for Intellipharmaceutics, which you can use to evaluate the volatility of the firm. Please check out Intellipharmaceutics' Market Risk Adjusted Performance of (0.62), downside deviation of 48.71, and Risk Adjusted Performance of 0.1305 to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Intellipharmaceutics OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
IPCIF
Based on monthly moving average Intellipharmaceutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Intellipharmaceutics by adding Intellipharmaceutics to a well-diversified portfolio.

Intellipharmaceutics OTC Stock Price History Chart

There are several ways to analyze Intellipharmaceutics Stock price data. The simplest method is using a basic Intellipharmaceutics candlestick price chart, which shows Intellipharmaceutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Intellipharmaceutics OTC Stock Price History Data

The price series of Intellipharmaceutics for the period between Fri, Sep 13, 2024 and Thu, Dec 12, 2024 has a statistical range of 0.05 with a coefficient of variation of 30.53. Under current investment horizon, the daily prices are spread out with arithmetic mean of 0.04. The median price for the last 90 days is 0.05. The company completed 1:10 stock split on 14th of September 2018. Intellipharmaceutics completed dividends distribution on 2018-09-14.
OpenHighLowCloseVolume
12/12/2024
 0.04  0.04  0.04  0.04 
07/24/2023 0.04  0.04  0.04  0.04  252.00 
07/21/2023 0.05  0.05  0.05  0.05  100.00 
07/20/2023 0.05  0.05  0.05  0.05  200.00 
07/19/2023 0.04  0.06  0.04  0.04  29,000 
07/18/2023 0.05  0.05  0.04  0.04  600.00 
07/17/2023 0.05  0.05  0.05  0.05  1.00 
07/14/2023 0.04  0.05  0.04  0.05  10,100 
07/13/2023 0.04  0.05  0.04  0.05  3,300 
07/12/2023 0.05  0.05  0.05  0.05  6.00 
07/11/2023 0.05  0.05  0.05  0.05  10,100 
07/10/2023 0.05  0.05  0.05  0.05  1.00 
07/07/2023 0.05  0.05  0.05  0.05  1.00 
07/06/2023 0.05  0.05  0.05  0.05  1.00 
07/05/2023 0.05  0.05  0.05  0.05  4,000 
07/03/2023 0.04  0.04  0.04  0.04  1.00 
06/30/2023 0.04  0.04  0.04  0.04  1.00 
06/29/2023 0.04  0.04  0.04  0.04  1.00 
06/28/2023 0.04  0.04  0.04  0.04  10.00 
06/27/2023 0.05  0.05  0.04  0.04  2,600 
06/26/2023 0.03  0.03  0.03  0.03  1.00 
06/23/2023 0.03  0.03  0.03  0.03  30.00 
06/22/2023 0.04  0.04  0.03  0.03  15,200 
06/21/2023 0.05  0.05  0.02  0.02  11,400 
06/20/2023 0.05  0.05  0.05  0.05  1.00 
06/16/2023 0.05  0.05  0.05  0.05  1,300 
06/15/2023 0.06  0.06  0.06  0.06  1,000.00 
06/14/2023 0.06  0.07  0.04  0.04  22,800 
06/13/2023 0.05  0.05  0.05  0.05  500.00 
06/12/2023 0.06  0.06  0.06  0.06  32.00 
06/09/2023 0.04  0.06  0.03  0.06  22,400 
06/08/2023 0.05  0.05  0.03  0.03  17,300 
06/07/2023 0.03  0.03  0.03  0.03  15,777 
06/06/2023 0.04  0.04  0.04  0.04  2,032 
06/05/2023 0.01  0.01  0.01  0.01  5,734 
06/02/2023 0.06  0.06  0.06  0.06  50.00 
06/01/2023 0.06  0.06  0.06  0.06  50.00 
05/31/2023 0.06  0.06  0.06  0.06  1,200 
05/30/2023 0.01  0.01  0.01  0.01  900.00 
05/26/2023 0.05  0.05  0.05  0.05  1.00 
05/25/2023 0.05  0.05  0.05  0.05  5,100 
05/24/2023 0.05  0.05  0.05  0.05  1,548 
05/23/2023 0.01  0.05  0.01  0.04  16,100 
05/22/2023 0.04  0.04  0.04  0.04  1.00 
05/19/2023 0.04  0.04  0.04  0.04  1.00 
05/18/2023 0.04  0.04  0.04  0.04  1.00 
05/17/2023 0.04  0.04  0.04  0.04  6,800 
05/16/2023 0.02  0.02  0.02  0.02  300.00 
05/15/2023 0.02  0.02  0.02  0.02  300.00 
05/12/2023 0.02  0.02  0.02  0.02  1,400 
05/11/2023 0.04  0.04  0.02  0.04  10,318 
05/10/2023 0.02  0.02  0.02  0.02  3,400 
05/09/2023 0.02  0.02  0.02  0.02  46,000 
05/08/2023 0.02  0.02  0.02  0.02  200.00 
05/05/2023 0.04  0.04  0.04  0.04  1.00 
05/04/2023 0.04  0.04  0.04  0.04  1.00 
05/03/2023 0.05  0.06  0.02  0.04  45,400 
05/02/2023 0.06  0.06  0.06  0.06  7,000 
05/01/2023 0.05  0.06  0.05  0.06  1,900 
04/28/2023 0.06  0.06  0.06  0.06  1.00 
04/27/2023 0.06  0.06  0.06  0.06  1.00 

About Intellipharmaceutics OTC Stock history

Intellipharmaceutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Intellipharmaceutics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Intellipharmaceutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Intellipharmaceutics stock prices may prove useful in developing a viable investing in Intellipharmaceutics
Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. The company was founded in 1998 and is based in Toronto, Canada. Intellipharmaceutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 11 people.

Intellipharmaceutics OTC Stock Technical Analysis

Intellipharmaceutics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Intellipharmaceutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Intellipharmaceutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Pattern Recognition Now

   

Pattern Recognition

Use different Pattern Recognition models to time the market across multiple global exchanges
All  Next Launch Module

Intellipharmaceutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Intellipharmaceutics' price direction in advance. Along with the technical and fundamental analysis of Intellipharmaceutics OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Intellipharmaceutics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Intellipharmaceutics OTC Stock

If you are still planning to invest in Intellipharmaceutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intellipharmaceutics' history and understand the potential risks before investing.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data